Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53166

言語	英語
著者	Yamaguchi Motoko Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan 鈴木律朗 Kim Seok Jin Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Ko Young Hyeh Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Oguchi Masahiko Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan Asano Naoko Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan Miyazaki Kana Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan Terui Yasuhiko Department of Hematology and Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan Kubota Nobuko Division of Hematology, Saitama Cancer Center, Ina, Japan Maeda Takeshi Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan Kobayashi Yukio Hematology Division, National Cancer Center Hospital, Tokyo, Japan Amaki Jun Division of Hematology & Oncology, Tokai University School of Medicine, Isehara, Japan Soejima Toshinori Department of Radiation Oncology, Hyogo Cancer Center, Akashi, Japan Saito Bungo Division of Hematology, Showa University School of Medicine, Tokyo, Japan Shimoda Emiko Department of Radiation Oncology, Nara Medical University, Kashihara, Japan Fukuhara Noriko Department of Hematology & Rheumatology, Tohoku University Hospital, Sendai, Japan Tsukamoto Norifumi Oncology Center, Gunma University Hospital, Maebashi, Japan Shimada Kazuyuki Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Choi Ilseung Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan Utsumi Takahiko Department of Hematology, Shiga Medical Center for Adults, Moriyama, Japan Ejima Yasuo Department of Radiology, Dokkyo Medical University, Shimotsuga, Japan Kim Won Seog Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Katayama Naoyuki Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
主題	concurrent chemoradiotherapy; early progression; Epstein-Barr virus; NK; T-cell lymphoma; soluble interleukin-2 receptor
掲載誌名	CANCER SCIENCE
巻	109
号	6
開始ページ	2056
終了ページ	2062
ISSN	1347-9032
ISSN（Online）	1349-7006
発行日	2018-06
DOI	10.1111/cas.13597
PubMed ID	29601137
出版者	WILEY
資料タイプ	学術雑誌論文
部局	医学部
備考	We thank the patients and doctors at the participating institutes (Appendix I) for their invaluable contributions to this cooperative study. This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (JSPS KAKENHI, grant numbers 26461418, 17K09924).